Clinical Trial Update: Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Meropenem-Vaborbactam to Piperacillin-Tazobactam in adults with complicated urinary tract infection and acute pyelonephritis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Meropenem-Vaborbactam (meropenem-vaborbactam)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | Status: COMPLETED | Results posted: 2017-10-26